loadpatents
Patent applications and USPTO patent grants for Feher; Miklos.The latest application filed is for "salt and crystal forms of plk-4 inhibitor".
Patent | Date |
---|---|
Salt And Crystal Forms Of Plk-4 Inhibitor App 20210269428 - Sampson; Peter Brent ;   et al. | 2021-09-02 |
Salt and crystal forms of PLK-4 inhibitor Grant 10,919,886 - Sampson , et al. February 16, 2 | 2021-02-16 |
Salt And Crystal Forms Of Plk-4 Inhibitor App 20200140428 - Sampson; Peter Brent ;   et al. | 2020-05-07 |
Pyrazolopyrimidine compounds Grant 10,570,143 - Liu , et al. Feb | 2020-02-25 |
Kinase inhibitors and method of treating cancer with same Grant RE47,731 - Sampson , et al. Nov | 2019-11-19 |
Salt and crystal forms of PLK-4 inhibitor Grant 10,472,353 - Sampson , et al. Nov | 2019-11-12 |
Salt and crystal forms of PLK-4 inhibitor Grant 10,392,374 - Sampson , et al. A | 2019-08-27 |
Salt And Crystal Forms Of Plk-4 Inhibitor App 20190248775 - Sampson; Peter Brent ;   et al. | 2019-08-15 |
Kinase inhibitors and method of treating cancer Grant 10,358,436 - Sampson , et al. | 2019-07-23 |
Pyrazolopyrimidine Compounds App 20190040074 - Liu; Yong ;   et al. | 2019-02-07 |
Pyrazolopyrimidine compounds Grant 10,106,545 - Liu , et al. October 23, 2 | 2018-10-23 |
Kinase Inhibitors And Method Of Treating Cancer App 20180282306 - Sampson; Peter Brent ;   et al. | 2018-10-04 |
Salt And Crystal Forms Of Plk-4 Inhibitor App 20180155335 - Sampson; Peter Brent ;   et al. | 2018-06-07 |
Kinase inhibitors and method of treating cancer Grant 9,907,800 - Sampson , et al. March 6, 2 | 2018-03-06 |
Salt and crystal forms of PLK-4 inhibitor Grant 9,884,855 - Sampson , et al. February 6, 2 | 2018-02-06 |
Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis Grant RE46,558 - Sherris , et al. September 26, 2 | 2017-09-26 |
Pyrazolopyrimidine Compounds App 20170217966 - Liu; Yong ;   et al. | 2017-08-03 |
Indazole compounds as kinase inhibitors and method of treating cancer with same Grant 9,580,390 - Pauls , et al. February 28, 2 | 2017-02-28 |
Pyrazolopyrimidine compounds Grant 9,573,954 - Liu , et al. February 21, 2 | 2017-02-21 |
Salt And Crystal Forms Of Plk-4 Inhibitor App 20160264559 - Sampson; Peter Brent ;   et al. | 2016-09-15 |
Methods of targeting PTEN mutant diseases and compositions therefor Grant 9,402,828 - Pan , et al. August 2, 2 | 2016-08-02 |
Kinase Inhibitors And Method Of Treating Cancer App 20160045511 - Sampson; Peter Brent ;   et al. | 2016-02-18 |
Pyrazolopyrimidine Compounds App 20150299203 - Liu; Yong ;   et al. | 2015-10-22 |
Kinase inhibitors and method of treating cancer Grant 9,139,563 - Sampson , et al. September 22, 2 | 2015-09-22 |
Methods Of Targeting Pten Mutant Diseases And Compositions Therefor App 20150182504 - Pan; Guohua ;   et al. | 2015-07-02 |
Kinase inhibitors and method of treating cancer with same Grant 8,999,968 - Sampson , et al. April 7, 2 | 2015-04-07 |
Methods of targeting PTEN mutant diseases and compositions therefor Grant 8,933,070 - Pan , et al. January 13, 2 | 2015-01-13 |
Indazole Compounds As Kinase Inhibitors And Method Of Treating Cancer With Same App 20140371202 - Pauls; Heinz W. ;   et al. | 2014-12-18 |
Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer Grant 8,765,748 - Pauls , et al. July 1, 2 | 2014-07-01 |
Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer Grant 8,680,282 - Pauls , et al. March 25, 2 | 2014-03-25 |
Kinase Inhibitors And Method Of Treating Cancer With Same App 20140051679 - Pauls; Heinz W. ;   et al. | 2014-02-20 |
Kinase Inhibitors And Method Of Treating Cancer App 20140045838 - Sampson; Peter Brent ;   et al. | 2014-02-13 |
Kinase Inhibitors And Method Of Treating Cancer With Same App 20140045822 - Sampson; Peter Brent ;   et al. | 2014-02-13 |
Kinase inhibitors and method of treating cancer Grant 8,481,533 - Sampson , et al. July 9, 2 | 2013-07-09 |
Kinase inhibitors and method of treating cancer with same Grant 8,481,525 - Sampson , et al. July 9, 2 | 2013-07-09 |
Methods Of Targeting Pten Mutant Diseases And Compositions Therefor App 20130123273 - Pan; Guohua ;   et al. | 2013-05-16 |
Inhibitors of carnitine palmitoyltransferase and treating cancer Grant 8,410,150 - Pauls , et al. April 2, 2 | 2013-04-02 |
Kinase Inhibitors And Method Of Treating Cancer App 20120264800 - SAMPSON; Peter Brent ;   et al. | 2012-10-18 |
Kinase inhibitors and method of treating cancer Grant 8,263,596 - Sampson , et al. September 11, 2 | 2012-09-11 |
Kinase Inhibitors And Method Of Treating Cancer With Same App 20120149686 - Sampson; Peter B. ;   et al. | 2012-06-14 |
Kinase Inhibitors And Method Of Treating Cancer App 20110263598 - Sampson; Peter B. ;   et al. | 2011-10-27 |
Indazolyl, Benzimidazolyl, Benzotriazolyl Substituted Indolinone Derivatives As Kinase Inhibitors Useful In The Treatment Of Cancer App 20110065702 - Pauls; Heinz W. ;   et al. | 2011-03-17 |
Cyclic Inhibitors Of Carnitine Palmitoyltransferase And Treating Cancer App 20110015174 - Pauls; Heinz W. ;   et al. | 2011-01-20 |
Inhibitors Of Carnitine Palmitoyltransferase And Treating Cancer App 20100105900 - Pauls; Heinz W. ;   et al. | 2010-04-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.